Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Multiple Myeloma 725Neoplasms, Plasma Cell 135Lymphoma, Non-Hodgkin 118Lymphoma 111Recurrence 103Leukemia, Lymphocytic, Chronic, B-Cell 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Leukemia, Myeloid, Acute 92Hodgkin Disease 92Lymphoma, Large B-Cell, Diffuse 83Leukemia 75Lymphoma, Mantle-Cell 71Myelodysplastic Syndromes 70Lymphoma, Follicular 69Burkitt Lymphoma 60Lymphoma, B-Cell, Marginal Zone 59Neoplasms 54Lymphoma, Large-Cell, Immunoblastic 54Waldenstrom Macroglobulinemia 42Myeloproliferative Disorders 39Leukemia, Myelomonocytic, Chronic 39Leukemia, Myeloid, Chronic-Phase 39Primary Myelofibrosis 38Immunoglobulin Light-chain Amyloidosis 38Hematologic Neoplasms 38Lymphoma, T-Cell, Cutaneous 36Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 35Lymphoma, Large-Cell, Anaplastic 34Leukemia, Myeloid, Accelerated Phase 34Blast Crisis 33

Interventions

saracatinib 1cediranib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Choriocarcinoma × Plasma cell × Clear all
NCT00475956 2010-04-15

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

AstraZeneca

Phase 1 Completed
40 enrolled
BreastGastrointestinalGynecologicPlasma cellThoracic

Breast Neoplasms, Choriocarcinoma, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡